SCHEMBL4259581

SCHEMBL4259581

Cc1ccc(C(=O)Nc2c(C(N)=O)oc3c(F)cc(F)cc23)o1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.53
POLB P06746 2/20 0.53
PKM P14618 1/20 0.53
KLK7 P49862 1/20 0.44
TP53 P04637 3/20 0.41
MAPK10 P53779 2/20 0.41
HSD17B10 Q99714 2/20 0.41
TSHR P16473 1/20 0.41
AHR P35869 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
PTGDR2 Q9Y5Y4 1/20 0.40
RAB9A P51151 3/20 0.40
LMNA P02545 2/20 0.40
HPGD P15428 2/20 0.40
HTT P42858 1/20 0.40
S1PR2 O95136 1/20 0.39
S1PR4 O95977 1/20 0.39
KDM4E B2RXH2 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4253483 0.87 TP53 (0.42) MAPTPOLBPKMTP53MAPK10
SCHEMBL13700045 0.86 MITF (0.44) MAPTPOLBPKMTP53MAPK10
SCHEMBL4255128 0.86 NPC1 (0.43) MAPTPOLBPKMTP53MAPK10
SCHEMBL13700052 0.84 MAPT (0.39) MAPTPOLBPKMTP53MAPK10
SCHEMBL13700228 0.83 SMYD3 (0.41) MAPTPOLBPKMTP53MAPK10
SCHEMBL13699816 0.83 MAPT (0.54) MAPTPOLBPKMKLK7TP53
SCHEMBL13699829 0.83 S1PR4 (0.49) MAPTTP53MAPK10HSD17B10TSHR
SCHEMBL4256297 0.82 MAPK10 (0.61) MAPTPOLBTP53MAPK10HSD17B10
SCHEMBL13700233 0.81 MAPT (0.40) MAPTPOLBPKMTP53MAPK10
SCHEMBL13699861 0.81 MAPT (0.62) MAPTPOLBTP53MAPK10HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US claimed
EP-1710233-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE Kissei Pharmaceutical Co., Ltd. (JP) 2006-10-11 EP claimed
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed
EP-1710233-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE Kissei Pharmaceutical Co., Ltd. (JP) 2006-10-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE ADORA2A, ADORA2B, HTR1F MAPT 4025/4885POLB 2255/4885PKM 2237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.